Press Release: Vidac Pharma : Vidac Pharma Announces Broad U.S. Patent Claim Allowance for HK2-Detaching Compounds in Cancer Treatment
Notice of Allowance Covers Compounds, Compositions, and Methods for Treating HK2-Expressing Cancers Vidac Pharma Holding Plc (XSTU:T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, September 30, 2025 /EINPresswire.com/ -- Vidac Pharma ...
Read full article »
Vidac Pharma develops medicines to help people suffering from oncologic and dermatologic medical conditions.
Read more